Sofiva Genomics Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sofiva Genomics Co Ltd

Watchlist Manager

Watchlist

Price: 33 TWD 0.3%

Market Cap: NT$712.5m

S	Sofiva Genomics Co Ltd TPEX:6615	TW
	Electronic City Indonesia Tbk PT IDX:ECII	ID
	Danske Bank A/S CSE:DANSKE	DK
	Asia Tele-Net and Technology Corporation Ltd HKEX:679	HK

Profitability Summary

Sofiva Genomics Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

27%

Sustainable 3Y Average Gross Margin

28%

Declining Gross Margin

29% > 27%

Negative Operating Margin

-5%

Negative 3Y Average Operating Margin

-4%

Declining Operating Margin

-2% > -5%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

7% > 4%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

Negative 3Y Average ROIC

-3%

Declining ROIC

-2% > -2%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.